- /
- Supported exchanges
- / US
- / STTK.NASDAQ
Shattuck Labs Inc (STTK NASDAQ) stock market data APIs
Shattuck Labs Inc Financial Data Overview
Shattuck Labs, Inc., a biotechnology company, develops antibodies for the treatment of inflammatory and immune-mediated diseases. The company's lead product candidate includes SL-325, a DR3 blocking monoclonal antibody, which activates immune responses through binding a single receptor, DR3; and SL-425. It also develops multiple preclinical DR3-based bispecific antibodies for the treatment of inflammatory bowel disease; and a series of bispecific antibodies targeting DR3 and other clinically validated targets. In addition, the company is involved in the advancement of its lead TRIM7 inhibitors through preclinical development as future internal pipeline candidates in oncology. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Shattuck Labs Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Shattuck Labs Inc data using free add-ons & libraries
Get Shattuck Labs Inc Fundamental Data
Shattuck Labs Inc Fundamental data includes:
- Net Revenue: 1 000 K
- EBITDA: -53 834 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-06
- EPS/Forecast: -0.1432
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shattuck Labs Inc News
New
Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium
Shattuck Labs, Inc. AUSTIN, TX and DURHAM, NC, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of no...
Shattuck earns new Overweight at Piper Sandler ahead of upcoming catalysts
[Republican Politics and Wall Street] Douglas Rissing Shares of Shattuck Labs (STTK [https://seekingalpha.com/symbol/STTK]) climbed on Wednesday after Piper Sandler launched its coverage with an Over...
Catalyst Watch: Big bank earnings, major healthcare + retail conferences, Fedspeak flurry, CPI
[Panoramic skyline of New York city at sunset, USA] Nico De Pasquale Photography Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read ...
Why Shattuck Labs Stock Soared in December
Key Points An analyst's recommendation upgrade had a major impact on investor sentiment. It's now a buy, according to the pundit.10 stocks we like better than Shattuck Labs › A recommendation upgr...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.